咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Ambiguous roles of innate lymp... 收藏

Ambiguous roles of innate lymphoid cells in chronic development of liver diseases

Ambiguous roles of innate lymphoid cells in chronic development of liver diseases

作     者:Yue Shen Jing Li Si-Qi Wang Wei Jiang 

作者机构:Department of Gastroenterology Zhongshan Hospital Fudan University Department of Gastroenterology Tongji Hospital Tongji University 

出 版 物:《World Journal of Gastroenterology》 (世界胃肠病学杂志(英文版))

年 卷 期:2018年第24卷第18期

页      面:1962-1977页

核心收录:

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基  金:Supported by National Nature Science Foundation of China,No.81670541 National Science and Technology Major Project,No.2013ZX10002004 and No.2017ZX10203202 

主  题:Innate lymphoid cells Chronic liver disease Hepatitis Liver fibrosis Liver cancer 

摘      要:Innate lymphoid cells(ILCs) are defined as a distinct arm of innate immunity. According to their profile of secreted cytokines and lineage-specific transcriptional factors, ILCs can be categorized into the following three groups: group 1 ILCs(including natural killer(NK) cells and ILC1 s) are dependent on T-bet and can produce interferon-γ; group 2 ILCs(ILC2 s) are dependent on GATA3 and can produce type 2 cytokines, including interleukin(IL)-5 and IL-13; and, group 3 ILCs(including lymphoid tissue-like cells and ILC3 s) are dependent on RORγt and can produce IL-22 and IL-17. Collaborative with adaptive immunity, ILCs are highly reactive innate effectors that promptly orchestrate immunity, inflammation and tissue repair. Dysregulation of ILCs might result in inflammatory disorders. Evidence regarding the function of intrahepatic ILCs is emerging from longitudinal studies of inflammatory liver diseases wherein they exert both physiological and pathological functions, including immune homeostasis, defenses and surveillance. Their overall effect on the liver depends on the balance of their proinflammatory and antiinflammatory populations, specific microenvironment and stages of immune responses. Here, we review the current data about ILCs in chronic liver disease progression, to reveal their roles in different stages as well as to discuss their therapeutic potency as intervention targets.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分